or Try an Advanced Search...

    Treatment Of Hypertension Stocks List

    Symbol Grade Name % Change
    BMY B Bristol-Myers Squibb Company 0.82
    MLYS F Mineralys Therapeutics, Inc. -3.65
    RDHL F Redhill Biopharma Ltd. 3.91
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Biopharmaceutical Hypertension Medicine Abdominal Pain Antibiotics Atrial Fibrillation Autoimmune Disease Bacteria Biopharmaceutical Products Cancer Treatment Cardiovascular Disease Chronic Myeloid Leukemia Clinic Clinical Medicine Crohn's Disease Depressive Disorder Diabetes Diabetic Nephropathy Dysfunction Dystrophy

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Hypertension stocks.

    Symbol Grade Name Weight
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 8.89
    MEDX F Horizon Kinetics Medical ETF 6.23
    PPH D Market Vectors Pharmaceutical ETF 5.89
    MVAL B SHL Telemedicine Ltd VanEck Morningstar Wide Moat Value ETF 5.37
    IHE D iShares U.S. Pharmaceutical ETF 5.27
    View all Treatment Of Hypertension ETFs...
    Compare ETFs
    Compare FTXH to MVAL Compare MEDX to PPH Compare PPH to MVAL

        Treatment Of Hypertension Stocks Recent News

        Date Stock Title
        Nov 21 BMY Major companies that are also popular short-selling stocks
        Nov 21 BMY Is Bristol Myers Squibb Stock a Buy?
        Nov 21 BMY Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks
        Nov 19 BMY Bristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript)
        Nov 19 BMY Bristol Myers Squibb’s Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms
        Nov 18 BMY Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
        Nov 18 BMY Is Bristol-Myers Squibb Company (BMY) the Best Immunotherapy Stock to Buy Now?
        Nov 18 BMY EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer
        Nov 17 BMY Bristol-Myers Squibb: Buy This Bargain Before It's Gone
        Nov 17 BMY Large Pension Doubled Palantir Stake, Bought Up Intel and CVS Stock
        Nov 15 BMY Large pharmas, biotechs down as industries grapple with RFK Jr. at HHS
        Nov 15 BMY Bristol Myers gets positive EMA opinion for repotrectinib
        Nov 15 BMY Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer
        Nov 15 BMY Bristol Myers Squibb Receives Positive CHMP Opinion for Repotrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer and Advanced NTRK-Positive Solid Tumors
        Nov 14 BMY Bristol Myers faces renewed, $6.7 billion lawsuit over delayed cancer drug
        Nov 14 BMY Tudor Investment adds Infinera, Trane, exits Disney, UnitedHealth, among top Q3 trades
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Biopharmaceutical Hypertension Medicine Abdominal Pain Antibiotics Atrial Fibrillation Autoimmune Disease Bacteria Biopharmaceutical Products Cancer Treatment Cardiovascular Disease Chronic Myeloid Leukemia Clinic Clinical Medicine Crohn's Disease Depressive Disorder Diabetes Diabetic Nephropathy Dysfunction Dystrophy
        Treatment Of Hypertension

        Treatment of hypertension typically involves lifestyle modifications such as reducing salt intake, increasing physical activity, and following a healthy diet. In addition, medications such as diuretics, beta-blockers, ACE inhibitors, and calcium channel blockers may be prescribed to help lower blood pressure.

        Browse All Tags